Herbalife: No Remedy for Investors

Stocks rose for the first time this week, as the Dow Jones Industrial Average (DJINDICES: ^DJI  ) and the broader S&P 500 (SNPINDEX: ^GSPC  ) gaining 0.5% and 0.3%, respectively.

Herbalife: No remedy for investors
Last month, activist investor Bill Ackman of Pershing Square Capital Management made a very public call against herbal supplements seller Herbalife (NYSE: HLF  ) , when he made a three-hour presentation of his "short" thesis for the stock at the annual Ira Sohn Investing Conference. Ackman pulled no punches, calling Herbalife a "pyramid scheme" and claiming that 90% of the profits Herbalife distributors earn derive from recruiting new distributors rather than from selling the company's products. The stock lost roughly a third of its value over the course of the next three days. Pershing Square is short more than 20 million shares of the stock.

Earlier today, it emerged that another well-known and very successful investor, Dan Loeb of Third Point Capital, has taken an 8% long position in the stock. In a letter to his investors, Loeb refutes the notion that Herbalife is a pyramid scheme, instead calling it a "classic compounder." He thinks the stock could go to $68. Third Point made one of the most lucrative contrarian bets in the hedge fund industry last year, snapping up Greek government bonds at the beginning of the year and subsequently roughly doubling their money to earn a $500 million profit.

In high-profile situations, individual investors may be tempted to piggyback on the investment of a star fund manager. However, in a case in which there is an obvious disagreement between two talented and thoughtful investors, it may be useful to invoke the observation of a third highly successful value investor -- the dean of the strategy -- Berkshire Hathaway (NYSE: BRK-B  ) CEO Warren Buffett, who told his shareholders at the 2006 annual meeting: "Charlie [Munger, Buffett's partner] says we have three boxes: In, Out, and Too Hard."

Ackman's team spent 18 months looking at Herbalife, bringing two law firms and forensic accountants onto the project. Dan Loeb isn't known for making investments on a whim, either. For non-professional investors, this one clearly belongs in the "Too Hard" box.

The Motley Fool's chief investment officer has selected his No. 1 stock for the next year. Find out which stock it is in our brand-new free report: "The Motley Fool's Top Stock for 2013." I invite you to take a copy, free for a limited time. Just click here to access the report and find out the name of this under-the-radar company.


Read/Post Comments (0) | Recommend This Article (5)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2188246, ~/Articles/ArticleHandler.aspx, 11/27/2014 7:32:53 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement